Sandu Pharmaceuticals Stock Price - ₹35.66 | Healthcare | askfuzz

Sign in to fuzzto save your conversations, follow your research and come back anytime.

‌

‌
‌

‌
‌
‌

‌
‌
‌
‌
‌
‌

Sandu Pharmaceuticals Stock Price - ₹35.66 | Healthcare | askfuzz

Quarterly Results

₹Cr

Metric (₹ crore)	Q1 FY22	Q2 FY22	Q4 FY22	Q1 FY23	Q2 FY23	Q3 FY23	Q4 FY23	Q1 FY24	Q2 FY24	Q3 FY24	Q4 FY24	Q1 FY25	Q2 FY25	Q3 FY25	Q4 FY25
Sales	17.34	17.59	11.42	16.23	16.76	17.09	15.26	17.66	16.61	17.43	15.6	17.05	17.7	18.37	14.07
Expenses	16.6	16.79	10.85	15.9	15.9	16.27	14.78	17.3	15.78	16.92	14.99	16.64	16.79	17.38	13.62
EBITDA	0.74	0.8	0.57	0.33	0.86	0.82	0.48	0.36	0.83	0.51	0.61	0.41	0.91	0.99	0.45
Depreciation	0.13	0.13	0.13	0.13	0.13	0.13	0.13	0.12	0.13	0.14	0.19	0.16	0.17	0.19	0.15
EBIT	0.61	0.67	0.44	0.2	0.73	0.69	0.35	0.24	0.7	0.37	0.42	0.25	0.74	0.8	0.3
Interest	0.04	0.05	0.02	0.02	0.02	0.02	0.02	0.02	0.01	0.02	0.01	0.02	0.03	0.03	0.03
Profit Before Tax	0.57	0.62	0.42	0.18	0.71	0.67	0.33	0.22	0.69	0.35	0.41	0.23	0.71	0.77	0.27
Net Profit	0.42	0.45	0.27	0.17	0.6	0.48	0.27	0.11	0.55	0.21	0.59	0.17	0.5	0.56	0.33
EPS	0.53	0.57	0.34	0.19	0.64	0.51	0.26	0.11	0.57	0.21	0.62	0.17	1.95	0.57	0.34

Cashflow

₹Cr

Metric (₹ crore)	FY23	FY24	FY25
Operating Cash Flow	0.22	0.76	0.95
Investing Cash Flow	0.54	-1.31	-0.19
Financing Cash Flow	0.58	-0.72	-0.46
Net Cash Flow	1.34	-1.27	0.3

Balance Sheet

Annual

₹Cr

Metric (₹ crore)	FY23	FY24	FY25
Equity / Shareholders' Funds	39.24	40.59	42.02
Total Liabilities	14.93	11.82	13.7
Total Assets	54.17	52.41	55.72

Shareholding

₹34 CrMarket Cap

Promoter & promoter group (37.79%)

Public & others (62.21%)